Related Experiment Video
Updated: Sep 1, 2025

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
Published on: May 10, 2017
Human Immunodeficiency Virus Associated Plasmablastic Lymphoma Involving Bones and Peritoneum in a 4-Year-old Child
Subramaniam Ramanathan1, Nirmalya Roy Moulik2, Chetan Dhamne2
1Department of Paediatric Oncology, Great North Children's Hospital, Newcastle-upon-Tyne, UK.
Insights
Pediatric non-Hodgkin lymphoma, specifically plasmablastic lymphoma, is rare but can occur in children with Human Immunodeficiency virus (HIV) infection and Acquired Immunodeficiency Syndrome (AIDS). Early treatment with chemotherapy and antiretroviral therapy led to remission in a young boy with knee joint plasmablastic lymphoma.
Area of Science:
- Pediatric Oncology
- Hematology
- Infectious Diseases
Background:
- Hematolymphoid cancers, particularly non-Hodgkin lymphomas, are prevalent in children with Human Immunodeficiency virus (HIV) infection and Acquired Immunodeficiency Syndrome (AIDS).
- Plasmablastic lymphoma (PBL) is an aggressive non-Hodgkin lymphoma subtype, typically affecting the head and neck region, and is exceptionally rare in pediatric populations.
- The occurrence of PBL in extranodal sites, such as the knee joint in HIV-infected children, presents a diagnostic and therapeutic challenge.
Observation:
- A 4-year-old boy with an underlying Human Immunodeficiency virus infection presented with a solitary bony swelling localized to the right knee joint.
- Diagnostic investigations confirmed the swelling to be a case of plasmablastic lymphoma, an unusual presentation for this specific malignancy in a pediatric patient.
- The patient's clinical course was meticulously monitored following diagnosis.
Findings:
- The diagnosis of plasmablastic lymphoma was established through comprehensive work-up of the knee joint swelling.
- The child received a treatment regimen comprising combination chemotherapy and intrathecal chemotherapy.
- Highly active anti-retroviral therapy (HAART) was initiated early in conjunction with cancer-directed treatment.
Implications:
- This case highlights the importance of considering rare presentations of plasmablastic lymphoma in immunocompromised children.
- The successful outcome underscores the efficacy of a multimodal treatment approach, including chemotherapy and early HAART, in managing pediatric plasmablastic lymphoma.
- Further research into the specific oncogenesis and optimal management strategies for extranodal plasmablastic lymphoma in HIV-infected children is warranted.
Abstract:
In children with underlying Human Immunodeficiency virus infection and AIDS, hematolymphoid cancers, especially non-hodgkin lymphomas are common. Plasmablastic lymphoma is one such non-hodgkin lymphomas arising from the head and neck region (especially sinonasal) but extremely rare. We describe the clinical course in a 4-year-old boy who presented with a solitary bony swelling of the right knee joint, which on diagnostic work-up turned out to be plasmablastic lymphoma. With combination chemotherapy, intrathecal chemotherapy, and early institution ofHighly active anti-retroviral therapy, the child continues to be in remission.
More Related Videos
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

